OCS Heart System Earns Hard-Won Backing of FDA Panel

After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support…

FDA Clears Device to Protect Kids Against Head Injury

The US Food and Drug Administration (FDA) has cleared a new over-the-counter device designed to protect children aged 13 years…

Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…